Results for tag: "Cardiometabolic Disease"

The Cardiometabolic Disease market is a subset of the Cardiology market that focuses on the diagnosis, treatment, and prevention of diseases related to the heart and metabolic system. Cardiometabolic diseases include conditions such as hypertension, diabetes, and obesity, which are all risk factors for cardiovascular disease. These diseases are often linked to lifestyle factors such as diet, physical activity, and smoking. Treatment options for cardiometabolic diseases include lifestyle modifications, medications, and surgery. Companies in the Cardiometabolic Disease market include pharmaceutical companies such as Novartis, Pfizer, and Merck, as well as medical device companies such as Medtronic, Abbott, and Boston Scientific. Additionally, there are a number of biotechnology companies that are developing new treatments for cardiometabolic diseases, such as Amgen, Gilead, and Regeneron. Show Less Read more